Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ELANE | P08246 | 2/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | PLG | P00747 | 1/20 | 0.31 |
| ▸ | CTSG | P08311 | 1/20 | 0.31 |
| ▸ | CMA1 | P23946 | 1/20 | 0.31 |
| ▸ | CTRC | Q99895 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | REN | P00797 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9818448 | 0.81 | PKM (0.34) | NPSR1PKMALDH1A1ELANEF2 | |
| SCHEMBL4732888 | 0.81 | PKM (0.34) | NPSR1PKMALDH1A1LMNAREN | |
| SCHEMBL4125062 | 0.74 | NPSR1 (0.33) | NPSR1PKMALDH1A1ELANEF2 | |
| SCHEMBL27092646 | 0.67 | CYP2C9 (0.39) | PKMALDH1A1LMNATDP1BACE1 | |
| SCHEMBL763669 | 0.63 | PKM (0.38) | PKMALDH1A1ELANEF2PLG | |
| SCHEMBL10632046 | 0.63 | ALDH1A1 (0.39) | PKMALDH1A1ELANELMNAREN | |
| SCHEMBL10636113 | 0.63 | ELANE (0.36) | PKMELANEF2CTSGCMA1 | |
| SCHEMBL5075817 | 0.63 | MMP2 (0.39) | NPSR1PKMALDH1A1LMNATDP1 | |
| SCHEMBL17830174 | 0.62 | HTR1A (0.46) | PKMALDH1A1LMNARENAPP | |
| SCHEMBL10629919 | 0.61 | MITF (0.43) | NPSR1ELANELMNATDP1BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070099900-A1 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-05-03 | — | — | US | claimed |
| WO-2006026048-A2 | BLEACHING WITH IMPROVED WHITENING | THE CLOROX COMPANY (US) | 2006-03-09 | — | — | WO | claimed |
| US-20060046946-A1 | Adding to wash water a granule or tablet containing a hypohalite-generating compound, a bromide-releasing compound, a fluorescent whitener; increases the measured textile whitening performance versus a control by a Delta W value of greater than 3.0 | THE CLOROX COMPANY | 2006-03-02 | — | — | US | claimed |
| US-7285522-B2 | Adding to wash water a granule or tablet containing a hypohalite-generating compound, a bromide-releasing compound, a fluorescent whitener; increases the measured textile whitening performance versus a control by a Delta W value of greater than 3.0 | THE CLOROX COMPANY (US) | 2007-10-23 | — | — | US | disclosed |
| US-20070099900-A1 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-05-03 | — | — | US | disclosed |
| US-20060046946-A1 | Adding to wash water a granule or tablet containing a hypohalite-generating compound, a bromide-releasing compound, a fluorescent whitener; increases the measured textile whitening performance versus a control by a Delta W value of greater than 3.0 | THE CLOROX COMPANY | 2006-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099900-A1 | Methods of modulating neurotrophin-mediated activity | NGF, BDNF, NTRK2 | NPSR1 26/4885PKM 3569/4885ALDH1A1 2086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.